INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -23.4% | 1,931 | -7.3% | 0.01% | -12.5% |
| Q2 2021 | $337,000 | +137.3% | 2,082 | +18.0% | 0.02% | +128.6% |
| Q1 2021 | $142,000 | +105.8% | 1,764 | -49.8% | 0.01% | +75.0% |
| Q3 2020 | $69,000 | -13.8% | 3,517 | -8.9% | 0.00% | -20.0% |
| Q2 2020 | $80,000 | +7900.0% | 3,860 | +3507.5% | 0.01% | – |
| Q1 2020 | $1,000 | -50.0% | 107 | -10.1% | 0.00% | – |
| Q2 2019 | $2,000 | – | 119 | +981.8% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 11 | -85.7% | 0.00% | – |
| Q1 2018 | $2,000 | -66.7% | 77 | -73.9% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | +50.0% | 295 | +74.6% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 169 | -46.9% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 318 | -17.8% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 387 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | – | 387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |